Posts

Generative AI – beyond the hype

Generative AI – beyond the hype

Jul 3, 2023

2023 started with a buzz around ChatGPT, and more generally around the immense p...

Cyltezo Pen: first interchangeable biosimilar to Humira rolls out across US

Cyltezo Pen: first interchangeable biosimilar to Humira...

Jul 3, 2023

The Humira biosimilar from Boehringer Ingelheim launches amidst a loss of exclus...

Eli Lilly’s retatrutide sets new record for weight loss in obesity space

Eli Lilly’s retatrutide sets new record for weight loss...

Jul 3, 2023

Pipeline developments within the obesity space have recently garnered interest f...

Chinese NMPA approves Innovent and IASO Bio’s myeloma therapy

Chinese NMPA approves Innovent and IASO Bio’s myeloma t...

Jul 3, 2023

China has granted approval for Innovent Biologics and IASO Bio Fucaso for treati...

Madrigal seeks expedited approval for NASH treatment

Madrigal seeks expedited approval for NASH treatment

Jul 3, 2023

Madrigal Pharmaceuticals has commenced a rolling submission of an NDA seeking ex...

Aston University appoints UK’s only Regius Professor of Pharmacy

Aston University appoints UK’s only Regius Professor of...

Jul 2, 2023

Credit: Aston University Professor Ian Wong has been appointed as Regius Profe...

STAT+: Medical leaders decry Supreme Court decision on affirmative action

STAT+: Medical leaders decry Supreme Court decision on ...

Jul 2, 2023

Medical leaders reacted swiftly to the Supreme Court’s decision on affirmative a...

STAT+: Supreme Court strikes down use of affirmative action, a blow to efforts to diversify medical schools

STAT+: Supreme Court strikes down use of affirmative ac...

Jul 2, 2023

The U.S. Supreme Court struck down the use of affirmative action, ruling that it...

Promising Results from Gelesis Study Show Stomach-Filling Capsule as Potential Alternative to GLP-1s for Weight Loss

Promising Results from Gelesis Study Show Stomach-Filli...

Jul 1, 2023

Gelesis, a company specializing in oral hydrogel technology, received FDA cleara...

Pfizer’s Breakthrough Treatment for Severe Alopecia Areata in Adolescents Receives FDA Approval

Pfizer’s Breakthrough Treatment for Severe Alopecia Are...

Jul 1, 2023

Alopecia areata, the most prevalent form of alopecia affecting individuals of al...

Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies

Vertex and Lonza Join Forces to Open New Manufacturing ...

Jul 1, 2023

Vertex Pharmaceuticals and Lonza have announced a strategic partnership to const...

Lilly Links Oral Obesity Drug to 15% Weight Loss, Setting the Bar for Pfizer in a Competitive Battle

Lilly Links Oral Obesity Drug to 15% Weight Loss, Setti...

Jul 1, 2023

Eli Lilly has set a benchmark in the oral obesity market by demonstrating a weig...

Eculizumab biosimilar by Turgut Ilaclari for Neuromyeli...

Jul 1, 2023

Eculizumab biosimilaris under clinical development by Turgut Ilaclari and curren...

(Glucagon + insulin human) by Abvance Therapeutics for ...

Jul 1, 2023

(Glucagon + insulin human)is under clinical development by Abvance Therapeutics ...

KP-910 by Kaken Pharmaceutical for Peripheral Neuropath...

Jul 1, 2023

KP-910is under clinical development by Kaken Pharmaceutical and currently in Pha...

[177Lu]Lu-rhPSMA-10.1 by Blue Earth Therapeutics for Me...

Jul 1, 2023

[177Lu]Lu-rhPSMA-10.1is under clinical development by Blue Earth Therapeutics an...